Skip to content
PodSubs
ShowsPeopleGuestsJobsNewsEvents
More
BlogPodCred
Menu
ShowsPeopleGuestsJobsNewsEventsBlogPodCredNetworksSign in
Join nowSign in
  • Shows
  • People
  • Jobs
  • News
  • More
    • Guests
    • Events
    • Blog
    • PodCred
    • Networks
    Join nowSign in

Off Script: A Pharma Manufacturing Podcast

Off Script: A Pharma Manufacturing Podcast artwork

Are Biomanufacturers Ready for AI?

Sep 22, 202627 minAudioEpisode 144
ShareXLinkedInFacebookWhatsAppEmail

While artificial intelligence is expected to transform biopharmaceutical manufacturing, many manufacturers still face challenges in adopting these technologies at scale. Fragmented data, disconnected manufacturing systems and differences in how information is shared across organizations are creating barriers to AI adoption, raising questions about what manufacturers need to prioritize before investing in more advanced tools. In this episode of Off Script, we spoke with Justin Byers, founder and CEO of Axio BioPharma, about some of the findings from the company's report, AI in Biomanufacturing: The 2026-2029 Outlook. The conversation explored the gap between AI ambitions and the reality of manufacturing facilities, the importance of building a strong data foundation, and how digital twins could support more advanced biomanufacturing processes. Byers also discussed the challenges of sharing manufacturing data across industry partners, the evolving regulatory expectations around AI in GMP environments, and how AI and digital technologies could reshape biologics manufacturing in the coming years.

Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.

Hosts and Guests

Nobody is credited on this episode yet.

Credit the people on this episode

Be the first to rate this episode

More episodes

All episodes
  1. Preparing the Pharma Workforce for Manufacturing Growth

    Nov 17, 202619 minAudio

    Ongoing investments to expand pharmaceutical manufacturing in the U.S. are creating demand for skilled workers, making it increasingly important to strengthen the talent pool to meet industry need. At the same time,...

    Credit the people on this episode

  2. How Engineered Yeast Could Reduce Biomanufacturing Costs

    Nov 10, 202624 minAudio

    In biomanufacturing, recovering intracellular bioproducts after fermentation can be a costly and energy-intensive process. To address this challenge, researchers are developing new approaches to reduce energy...

    Credit the people on this episode

  3. Adapting Drug Development in a Tighter Funding Environment

    Nov 3, 202616 minAudio

    Tighter funding conditions are putting greater pressure on emerging biotech to reach key development milestones quickly while managing limited budgets. That environment is also changing what sponsors expect from their...

    Credit the people on this episode

  4. How Manufacturers Manage Pipelines in an Uncertain Market

    Oct 27, 202630 minAudio

    Despite ongoing geopolitical and regulatory pressures, life sciences manufacturers continue to invest in their product pipelines while also being more deliberate about long-term portfolio decisions. As interest in...

    Credit the people on this episode

  5. Solutions Spotlight: Applying Flow Chemistry to Complex Pharmaceutical Manufacturing

    Oct 23, 202625 minAudio

    Pharmaceutical manufacturers working with hazardous and difficult-to-control chemical reactions face challenges in managing process safety, heat transfer, and reaction conditions. Flow chemistry offers an alternative to...

    Credit the people on this episode